Surpass Inc. is a contract research organization (CRO) specialized in providing comprehensive preclinical research services for medical devices, pharmaceuticals, biologics, and combination products. The company is a GLP-compliant, AAALAC-accredited, and USDA-registered laboratory with a regulatory infrastructure designed to support a variety of study design needs. Surpass conducts acute feasibility through chronic GLP studies and can support procedure development as well as physician evaluations, training, and education.